itraconazole has been researched along with Disease Models, Animal in 3 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral posaconazole therapy was started 24 h after infection and was given once daily for 14 consecutive days." | 1.36 | Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene. ( Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mavridou, E | 1 |
| Brüggemann, RJ | 1 |
| Melchers, WJ | 1 |
| Mouton, JW | 1 |
| Verweij, PE | 1 |
| Calvo, E | 1 |
| Pastor, FJ | 1 |
| Rodríguez, MM | 1 |
| Mayayo, E | 1 |
| Salas, V | 1 |
| Guarro, J | 1 |
| MacCallum, DM | 1 |
| Coste, A | 1 |
| Ischer, F | 1 |
| Jacobsen, MD | 1 |
| Odds, FC | 1 |
| Sanglard, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. A Prospective Multicenter Observational Study.[NCT03121235] | 320 participants (Actual) | Observational | 2017-04-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for itraconazole and Disease Models, Animal
| Article | Year |
|---|---|
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumig | 2010 |
Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
Topics: Animals; Antifungal Agents; Ascomycota; Brain; Disease Models, Animal; Kidney; Liver; Lung; Male; Mi | 2010 |
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Disease Models, Animal; DN | 2010 |